The DOI matches its Crossref record; 214 of the 214 references it cites were found in a registry or an index.
Docking Screens for Novel Ligands Conferring New Biology: Miniperspective
Open accessAbstract
It is now plausible to dock libraries of 10 million molecules against targets over several days or weeks. When the molecules screened are commercially available, they may be rapidly tested to find new leads. Although docking retains important liabilities (it cannot calculate affinities accurately nor even reliably rank order high-scoring molecules), it can often can distinguish likely from unlikely ligands, often with hit rates above 10%. Here we summarize the improvements in libraries, target quality, and methods that have supported these advances, and the open access resources that make docking accessible. Recent docking screens for new ligands are sketched, as are the binding, crystallographic, and in vivo assays that support them. Like any technique, controls are crucial, and key experimental ones are reviewed. With such controls, docking campaigns can find ligands with new chemotypes, often revealing the new biology that may be docking's greatest impact over the next few years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–214 of 214
Jian-hu, X., Zhang, S., Luo, M., Zou, Y., Zhang, Y., & Lai, Y. (2015) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2015.05.005 · Cited by 15
Park, H., Chien, P. N., & Ryu, S. E. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.08.081 · Cited by 15
Chandra, N. R., Bhagavat, R., Sharma, E., Sreekanthreddy, P., & Somasundaram, K. (2011) · Journal of Clinical Bioinformatics · doi:10.1186/2043-9113-1-5 · Cited by 15
Pinheiro, A. S., Duarte, J. B. C., Alves, C. N., & de Molfetta, F. A. (2015) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-015-1672-5 · Cited by 14
The Impact of Introducing a Histidine into an Apolar Cavity Site on Docking and Ligand Recognition
Merski, M., & Shoichet, B. K. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301823g · Cited by 14
Self-citationVirtual screening of novel reversible inhibitors for marine alkaline protease MP
Ji, X., Zheng, Y., Wang, W., Sheng, J., Hao, J., & Sun, M. (2013) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2013.10.004 · Cited by 13
Pei, F., Jin, H., Zhou, X., Xia, J., Sun, L., Liu, Z., & Zhang, L. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12590 · Cited by 13
Comparative Modeling of Drug Target Proteins☆
Webb, B., Eswar, N., Fan, H., Khuri, N., Pieper, U., Dong, G., & Šali, A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.11133-3 · Cited by 12
Computer-aided discovery of aminopyridines as novel JAK2 inhibitors
Zhao, C., Yang, S., Khadka, D. B., Jin, Y., Lee, K., & Cho, W. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.01.016 · Cited by 11
Discovery of new potent inhibitors for carbonic anhydrase IX by structure-based virtual screening
Wang, L., Yang, C., Lü, W., Liu, L., Gao, R., Liao, S., Zhao, Z., Zhu, L., Xu, Y. F., Li, H., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.04.048 · Cited by 11
Discovery of Novel GSK-3β Inhibitors Using Pharmacophore and Virtual Screening Studies
Balakrishnan, N., Raj, J. S., & Kandakatla, N. (2015) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-015-0100-4 · Cited by 6
Mitra, J., Narad, P., Sengupta, A., Sharma, P. D., & Paul, P. K. (2015) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-015-0105-z · Cited by 6
Ramirez, U. D., Nikonova, A. S., Liu, H., Pecherskaya, A., Lawrence, S. H., Serebriiskii, I. G., Zhou, Y., Robinson, M. K., Einarson, M. B., Golemis, E. A., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1415-6 · Cited by 5
Design of inhibitors of the HIV-1 integrase core domain using virtual screening
Regon, P., Gogoi, D., Rai, A. K., Bordoloi, M., & Bezbaruah, R. L. (2014) · Bioinformation · doi:10.6026/97320630010076 · Cited by 2
Cited by
Ultra-large library docking for discovering new chemotypes
Lyu, J., Wang, S., Balius, T. E., Singh, I., Levit, A., Moroz, Y. S., O’Meara, M. J., Che, T., Algaa, E., Tolmachova, K., et al. (2019) · Nature · doi:10.1038/s41586-019-0917-9 · Cited by 998
Self-citationComputational methods in drug discovery
Leelananda, S. P., & Lindert, S. (2016) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.12.267 · Cited by 639
A practical guide to large-scale docking
Bender, B. J., Gahbauer, S., Luttens, A., Lyu, J., Webb, C. M., Stein, R. M., Fink, E. A., Balius, T. E., Carlsson, J., Irwin, J. J., et al. (2021) · Nature Protocols · doi:10.1038/s41596-021-00597-z · Cited by 546
“For instance, docking typically undersamples conformational states, ignores important terms (e.g., ligand strain) and approximates terms that it does include (e.g., fi xed potentials) 19,20 .”
BackgroundSelf-citationEfficient Exploration of Chemical Space with Docking and Deep Learning
Yang, Y., Yao, K., Repasky, M. P., Leswing, K., Abel, R., Shoichet, B. K., & Jerome, S. V. (2021) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.1c00810 · Cited by 442
Self-citationSynthon-based ligand discovery in virtual libraries of over 11 billion compounds
Sadybekov, A. A., Sadybekov, A. V., Liu, Y., Iliopoulos-Tsoutsouvas, C., Huang, X.-P., Pickett, J., Houser, B., Patel, N., Tran, N. K., Tong, F., et al. (2022) · Nature · doi:10.1038/s41586-021-04220-9 · Cited by 417
“Standard libraries for high-throughput screening (HTS) 10 and virtual ligand screening (VLS) 11–13 have been historically limited to fewer than 10 million available compounds, which is a small fraction of the enormous chemical space, estimated to be 10 20 to 10 60 drug-like compounds 14,15 .”
Background
Metadata
- Authors
- Irwin, J. J., & Shoichet, B. K.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-03-15
- Volume
- 59
- Issue
- 9
- Pages
- 4103-4120
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2274656763
- Cited by
- 277
- References
- 214
- FWCI
- 32.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.